Global Multiplex Detection Immunoassay Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Multiplex Detection Immunoassay Market is presumed to reach the market size of nearly USD 5.54 Billion by 2032 from USD 2.76 Billion in 2023 with a CAGR of 8.05% under the study period 2024-2032.

Multiplex detection immunoassay is a type of immunoassay that simultaneously measures multiple analytes in a single experiment using magnetic beads or solid surfaces. It allows for the rapid profiling of biomarker proteins in biological fluids, using less sample and labor than single immunoassays. The technology yields a wealth of information on the roles of multiple proteins and other biomolecules in diverse biological processes, thereby providing clinicians with insight into the identification and assessment of disease progression.

MARKET DYNAMICS

The global multiplex detection immunoassay market is projected to grow at a remarkable rate during the forecast period. Multiplex detection immunoassay is gaining robust popularity due to its capability to detect, identify, and monitor dozens of proteins simultaneously, reducing workflow plus sample volume problems, and provides a gain in dynamic assay range. Increasing R & D activities across, rising incidence of chronic and infectious disease, massive research, valuations and approvals of medicines, and the rise in geriatric population are also steering the market's global growth. In addition, emerging economies, thriving companion diagnostics, and other advancing technologies in the healthcare and pharmaceutical industry are estimated to create opportunities for the market. However, inadequate support from the government for research and lack of skilled professionals, and inadequate financial support obstruct demand for multiplex detection immunoassay.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Multiplex Detection Immunoassay. The growth and trends of Multiplex Detection Immunoassay industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Multiplex Detection Immunoassay market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Assay Type

Planar Assay
Blends Protein Arrays (multiplexed ELISA)
Antibody Arrays
Bead-based Assay
Magnetic Bead-based
Non-magnetic Bead-based

By Technique

Nucleic Acid-based Techniques
Protein-based Techniques
Biosensor-based Techniques

By Application

Disease Testing (Infectious Disease Testing, Autoimmune Disease Testing, Other Diseases Testing)
Food Contamination Testing
Research & Development
Veterinary Disease Testing

By End User

Pharmaceutical & Biopharmaceutical Companies
Clinical Research Organizations
Food & Beverages Industry
Academic & Research Institutes
Diagnostic Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Multiplex Detection Immunoassay market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Multiplex Detection Immunoassay market include Hoffmann-La Roche Ltd, QIAGEN, Merck KGaA, Microsynth AG, Bio-Rad Laboratories, Thermo Fisher Scientific, Luminex Corporation, Becton, Dickinson And Company. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11215056

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. MULTIPLEX DETECTION IMMUNOASSAY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Assay Type
- 3.7.2 Market Attractiveness Analysis By Technique
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End User
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL MULTIPLEX DETECTION IMMUNOASSAY MARKET ANALYSIS BY ASSAY TYPE

5.1. Overview By Assay Type
5.2. Historical and Forecast Data Analysis By Assay Type
5.3. Planar Assay Historic and Forecast Sales By Regions
5.4. Blends Protein Arrays (multiplexed ELISA) Historic and Forecast Sales By Regions
5.5. Antibody Arrays Historic and Forecast Sales By Regions
5.6. Bead-based Assay Historic and Forecast Sales By Regions
5.7. Magnetic Bead-based Historic and Forecast Sales By Regions
5.8. Non-magnetic Bead-based Historic and Forecast Sales By Regions

6. GLOBAL MULTIPLEX DETECTION IMMUNOASSAY MARKET ANALYSIS BY TECHNIQUE

6.1. Overview By Technique
6.2. Historical and Forecast Data Analysis By Technique
6.3. Nucleic Acid-based Techniques Historic and Forecast Sales By Regions
6.4. Protein-based Techniques Historic and Forecast Sales By Regions
6.5. Biosensor-based Techniques Historic and Forecast Sales By Regions

7. GLOBAL MULTIPLEX DETECTION IMMUNOASSAY MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data Analysis By Application
7.3. Disease Testing (Infectious Disease Testing, Autoimmune Disease Testing, Other Diseases Testing) Historic and Forecast Sales By Regions
7.4. Food Contamination Testing Historic and Forecast Sales By Regions
7.5. Research & Development Historic and Forecast Sales By Regions
7.6. Veterinary Disease Testing Historic and Forecast Sales By Regions

8. GLOBAL MULTIPLEX DETECTION IMMUNOASSAY MARKET ANALYSIS BY END USER

8.1. Overview By End User
8.2. Historical and Forecast Data Analysis By End User
8.3. Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales By Regions
8.4. Clinical Research Organizations Historic and Forecast Sales By Regions
8.5. Food & Beverages Industry Historic and Forecast Sales By Regions
8.6. Academic & Research Institutes Historic and Forecast Sales By Regions
8.7. Diagnostic Centers Historic and Forecast Sales By Regions
8.8. Others Historic and Forecast Sales By Regions

9. GLOBAL MULTIPLEX DETECTION IMMUNOASSAY MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE MULTIPLEX DETECTION IMMUNOASSAY COMPANIES

10.1. Multiplex Detection Immunoassay Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF MULTIPLEX DETECTION IMMUNOASSAY INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Hoffmann-La Roche Ltd
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. QIAGEN
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Merck KGaA
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Microsynth AG
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Bio-Rad Laboratories
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Thermo Fisher Scientific
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Luminex Corporation
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Becton
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Dickinson And Company
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies